Viewing Study NCT03126461


Ignite Creation Date: 2025-12-24 @ 1:06 PM
Ignite Modification Date: 2026-02-07 @ 11:36 AM
Study NCT ID: NCT03126461
Status: WITHDRAWN
Last Update Posted: 2020-08-20
First Post: 2017-03-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
Sponsor: University of Texas Southwestern Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Metastatic Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic melanoma View